Optical molecular imaging developer ART Advanced Research Technologies of Montreal has received an order from the University Medical Center Göttingen in Germany for its SoftScan breast imaging system.
The medical center currently owns an ART Optix preclinical imaging system and plans to use SoftScan to further its development of cancer monitoring and explore new therapies.
Related Reading
ART posts revenue gain in Q3, November 17, 2008
Road to RSNA, Women's Imaging, ART Advanced Research Technologies, October 28, 2008
ART signs UCLA, September 11, 2008
ART grows revenues in Q2, August 18, 2008
ART wins financing, August 7, 2008
Copyright © 2009 AuntMinnie.com